Sunday 11 October 2026 Export all OHI data to Excel Powerpack

Omega Healthcare Investors, Inc.

OHI Real Estate Reit Healthcare Facilities

Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024. In the quarter to June 2026, revenue grew 16.2%, EPS grew 163.0%, free cash flow grew 710.6% and total debt fell 99.9%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three; insiders bought in the last twelve months.

44.41 0.27 +0.61%
Market cap
$13.4B
P/E
15.7×
Fwd P/E
22.5×
Dividend yield
6.05%
F-score
6/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Revenue
1,282.01 1,236.27 1,190.10 1,150.20

+8 more TTM periods

Gross Profit
1,282.01 1,236.27 1,190.10 1,150.20
SG&A Expenses
116.78 98.10 104.14 101.72
Operating Income
794.05 768.93 717.11 694.46
Non-operating Income/Expense
108.27 (99.18) (92.68) (122.67)
Non-operating Interest Expenses
207.73 212.51 215.04 218.53
EBT
902.32 669.76 624.43 571.78
Income Tax Provision
16.33 16.24 14.75 15.60
Income after Tax
885.99 653.52 609.69 556.18
Share of Subsidiary Earnings
9.18 2.47 (0.22) (2.22)
Dividends (Preferred)
(20.69) (20.99) (19.36) 3.36
Non-Controlling Interest
61.81 48.84 44.35 17.12
Net Income Common
878.43 639.54 591.39 540.39
EPS (Basic)
2.83 2.08 1.95 1.81
EPS (Diluted)
2.80 2.07 1.93 1.79
Shares (Basic, Weighted)
295.84 293.93 290.42 282.04
Shares (Diluted, Weighted)
311.13 307.87 302.82 294.20
Gross Margin
100.00% 100.00% 100.00% 100.00%
EBIT Margin
61.94% 62.20% 60.26% 60.38%
EBT margin
70.38% 54.18% 52.47% 49.71%
Net Profit Margin
68.52% 51.73% 49.69% 46.98%
Free Cash Flow Margin
64.92% 5.70% 6.81% 13.45%
EBITDA
1,130.27 1,100.81 1,043.33 1,020.59
EBIT
794.05 768.93 717.11 694.46
EPS (Diluted, from Cont. Ops)
2.86 2.12 2.00 1.85
EPS (Diluted, Consolidated)
2.86 2.12 2.00 1.85
EPS (Basic, Consolidated)
3.02 2.23 2.09 1.93
Shares (Diluted, Average)
311.92 311.51 304.89 298.45
EPS (Basic, from Continuous Ops)
3.02 2.23 2.09 1.93
Income from Continuous Operations
895.17 655.98 609.47 553.96
Consolidated Net Income/Loss
895.17 655.98 609.47 553.96
EBITDA Margin
88.16% 89.04% 87.67% 88.73%
Operating Cash Flow Margin
69.47% 73.78% 73.82% 76.24%

Fold the line items

In millions of $ except per-share values · columns are period end dates